The global in situ hybridization market is segmented by technique, application, end-user, and region. It is divided into two types based on technique: fluorescence in situ hybridization (FISH) and chromogenic in situ hybridization (CISH) (CISH). It is classified into cancer diagnosis, immunology, neuroscience, cytology, and infectious diseases based on its application. It is divided into molecular diagnostic laboratories, pharmaceutical and biotechnology companies, contract research organizations (CROS), and academic and research institutions based on end-user. It is divided into four regions: North America, Europe, Asia-Pacific, and Latin America, and the Caribbean.
Furthermore, in-situ hybridization reveals the location of gene expression in the cellular environment. Fluorescence in situ hybridization (FISH) and chromogenic in situ hybridization (CISH) are two types of in situ hybridization used to identify gene positions, which provide useful information about tumors.
Read more @ https://bit.ly/3J4ONsL